Weiss Multi-Strategy Advisers LLC - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 86 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.

Quarter-by-quarter ownership
Weiss Multi-Strategy Advisers LLC ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$34
-29.2%
48,894
-9.5%
0.00%0.0%
Q1 2023$48
-37.7%
54,054
-16.8%
0.00%
-50.0%
Q4 2022$77
-100.0%
65,000
-35.0%
0.00%
-90.0%
Q3 2022$753,000
-15.1%
100,000
-29.0%
0.02%
-25.9%
Q2 2022$887,000
-31.1%
140,749
-9.2%
0.03%
-10.0%
Q1 2022$1,287,000
+18.4%
155,000
-26.0%
0.03%
+20.0%
Q4 2021$1,087,000
-23.6%
209,428
-1.7%
0.02%
-19.4%
Q3 2021$1,423,000
-19.3%
213,000
+2.9%
0.03%
-20.5%
Q2 2021$1,764,000
-0.3%
207,000
+3.5%
0.04%0.0%
Q1 2021$1,770,000
-27.1%
200,000
+1.2%
0.04%
-17.0%
Q4 2020$2,428,000
+55.3%
197,547
+2.9%
0.05%
+11.9%
Q3 2020$1,563,000
-12.0%
192,000
+3.8%
0.04%
-17.6%
Q2 2020$1,776,000
+67.4%
185,000
+18.6%
0.05%
+24.4%
Q1 2020$1,061,000
-52.5%
156,000
+4.0%
0.04%
+10.8%
Q4 2019$2,235,000
+55.7%
150,000
+7.1%
0.04%
+27.6%
Q3 2019$1,435,000
+4.1%
140,000
+7.7%
0.03%
-19.4%
Q2 2019$1,378,000
-6.1%
130,000
+23.8%
0.04%
-2.7%
Q1 2019$1,468,000
+37.6%
105,0000.0%0.04%
-15.9%
Q4 2018$1,067,000
+154.0%
105,000
+200.0%
0.04%
+300.0%
Q3 2018$420,00035,0000.01%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Vivo Capital, LLC 1,787,091$20,462,0006.02%
INTERWEST VENTURE MANAGEMENT CO 1,599,592$18,315,0003.89%
NEXTHERA CAPITAL LP 263,600$3,018,0001.54%
SPHERA FUNDS MANAGEMENT LTD. 385,301$4,412,0000.86%
RA Capital Management 354,200$4,056,0000.50%
DAFNA Capital Management LLC 35,977$412,0000.35%
Boxer Capital, LLC 138,331$1,584,0000.35%
SABBY MANAGEMENT, LLC 238,907$2,735,0000.15%
Monashee Investment Management LLC 31,500$361,0000.14%
Lombard Odier Asset Management (USA) Corp 100,000$1,145,0000.11%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders